Therapeutic Drugs External Quality Assessment

The RIQAS Therapeutic Drug EQA programme is designed to monitor the performance of an impressive 18 therapeutic drugs. Weighed in values are reported for each parameter.

  • Accredited to ISO/IEC 17043
  • Lyophilised for enhanced stability
  • 100% human serum
  • Bi-weekly reporting
  • Submit results and view reports online via RIQAS.Net
  • Register up to five instruments at no extra cost
  • Weighed in values reported for each parameter
Cat NoKit SizeFrequencyCycle StartParameters 
RQ911112 x 5mlBi-weekly (2 x 6 monthly cycles)March / Sept18

[ddownload class="button tiny secondary" id="4305" text="Enrolment Document"]

[ddownload class="button tiny secondary" id="4307" text="Method Questionnaire"]

[ddownload class="button tiny secondary" id="2976" text="Instrument & Reagent Codes"]


Parameters

  • Amikacin
  • Caffeine
  • Carbamazepine
  • Cyclosporine
  • Digoxin
  • Ethosuximide
  • Gentamicin
  • Lithium
  • Methotrexate
  • Paracetamol
  • Phenobarbital
  • Phenytoin
  • Primidone
  • Salicylic Acid
  • Theophylline
  • Tobramycin
  • Valproic Acid
  • Vancomycin
Clinical Laboratory Survey